Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028–study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation

Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028–study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation

Introduction Despite antiretroviral therapy (ART), people living with HIV have higher rates of non-infectious chronic diseases. These conditions are driven by relatively high levels of inflammation persisting on ART compared with uninfected individuals. Chron…

Read More…

Leave a Reply

Your email address will not be published. Required fields are marked *